Insider · CIK 0001237610
John F Kuntz
Files at BLFY (Blue Foundry Bancorp). First filing -, latest -.
In brief
John F Kuntz files SEC Form 4 as director at BLFY (Blue Foundry Bancorp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John F Kuntz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | BLFY Blue Foundry Bancorp | DDisposition to issuer Common Stock | -21,255 | - | - | 0 | Apr 1, 2026 |
| Mar 30, 2026 | BLFY Blue Foundry Bancorp | DDisposition to issuer Stock Optionsderivative | -48,133 | - | - | 0 | Apr 1, 2026 |
| Nov 1, 2024 | BLFY Blue Foundry Bancorp | AGrant or award Common Stock | +19,255 | $0.00 | $0 | 21,255 | Nov 5, 2024 |
| Nov 1, 2024 | BLFY Blue Foundry Bancorp | AGrant or award Stock Optionsderivative | +48,133 | $0.00 | $0 | 48,133 | Nov 5, 2024 |
Questions about John F Kuntz
Answered from the filings on this page, as of the latest one.
Is John F Kuntz buying or selling?
John F Kuntz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John F Kuntz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John F Kuntz has 0.
Where does John F Kuntz file Form 4?
John F Kuntz has filed Form 4 at BLFY (Blue Foundry Bancorp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.